Beeckman, DSA, Vanrompay, DCG. Zoonotic Chlamydophila psittaci infections from a clinical perspective. Clinical Microbiology and Infection
2009; 15: 11–17.
Halsby, KD, et al.
Healthy animals, healthy people: zoonosis risk from animal contact in pet shops, a systematic review of the literature. PLoS ONE
2014; 9: e89309.
Heddema, ER, et al.
An outbreak of psittacosis due to Chlamydophila psittaci genotype A in a veterinary teaching hospital. Journal of Medical Microbiology
2006; 55: 1571–1575.
Belchior, E, et al.
Psittacosis outbreak after participation in a bird fair, Western France, December 2008. Epidemiology and Infection
2011; 139: 1637–1641.
Laroucau, K, et al.
Outbreak of psittacosis in a group of women exposed to Chlamydia psittaci-infected chickens. Eurosurveillance
2015; 20: pii=21155.
Dickx, V, et al.
Chlamydophila psittaci zoonotic risk assessment in a chicken and Turkey slaughterhouse. Journal of Clinical Microbiology
2010; 48: 3244–3250.
Vorimore, F, et al.
Chlamydia psittaci in ducks: a hidden health risk for poultry workers. Pathogens and Disease
2015; 73: 1–9.
van der Hoek, W, et al.
Extent of the psittacosis problem in humans: the importance of reliable diagnostics [in Dutch]. Infectieziekten Bulletin
2014; 25: 45–48.
Heddema, ER, et al.
Typing of Chlamydia psittaci to monitor epidemiology of psittacosis and aid disease control in the Netherlands, 2008 to 2013. Eurosurveillance
2015; 20: pii=21026.
Grayston, JT, et al.
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. New England Journal of Medicine
1986; 315: 161–168.
Moher, D, et al.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine
2009; 6: e1000097.
Nyaga, VN, Arbyn, M, Aerts, M. Metaprop: a Stata command to perform meta-analysis of binomial data. Archives of Public Health
2014; 72: 39.
Krech, T, et al.
Etiology of atypical pneumonias: a serological study on 1494 patients [in German]. Schweizerische Medizinische Wochenschrift
1986; 116: 2–7.
Jokinen, C, et al.
Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clinical Infectious Diseases
2001; 32: 1141–1154.
Claesson, BA, et al.
Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatric Infectious Disease Journal
1989; 8: 856–862.
Harrison, BDW, et al.
Community-acquired pneumonia in adults in British hospitals in 1982–1983: a survey of aetiology, mortality , prognostic factors and outcome. Querterly Journal of Medicine
1987; 62: 195–220.
Burman, LÅ, et al.
Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. Journal of Infectious Diseases
1991; 163: 1087–1093.
Mohamed, ARE, Price Evans, DA. The spectrum of pneumonia in 1983 at the Riyadh Armed Forces Hospital. Journal of Infection
1987; 14: 31–37.
Ausina, V, et al.
Prospective study on the etiology of community-acquired pneumonia in children and adults in Spain. European Journal of Clinical Microbiology & Infectious Diseases
1988; 7: 343–347.
Blanquer, J, et al.
Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study. Thorax
1991; 46: 508–511.
Mensa, J, et al.
Treatment of atypical pneumonia with josamycin [in Spanish]. Medicina Clínica
1989; 92: 285–287.
Ekman, MR, et al.
Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. European Journal of Clinical Microbiology & Infectious Diseases
1993; 12: 756–760.
Örtqvist, A, et al.
Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. European Respiratory Journal
1990; 3: 1105–1113.
Lim, WS, et al.
Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax
2001; 56: 296–301.
Aderaye, G. Community acquired pneumonia in adults in Addis Ababa: etiologic agents and the impact of HIV infection. Tubercle and Lung Disease
1994; 75: 308–312.
Moine, P, et al.
Severe community-acquired pneumonia: etiology, epidemiology, and prognosis factors. Chest
1994; 105: 1487–1495.
Almirall, J, et al.
Differences in the etiology of community-acquired pneumonia according to site of care: a population-based study. Respiratory Medicine
2007; 101: 2168–2175.
Ouchi, K, et al.
Prevalence of chlamydia pneumoniae in acute lower respiratory infection in the pediatric population in Japan. Acta Paediatrica Japonica
1994; 36: 256–260.
Torzillo, P, et al.
Etiology of acute lower respiratory tract infection in Central Australian Aboriginal children. Pediatric Infectious Disease Journal
1999; 18: 714–721.
The Nordic Atypical Pneumonia Study Group. Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Journal of Antimicrobial Chemotherapy
1997; 39: 499–508.
Barnes, DJ, et al.
The role of viruses and atypical organisms in the pathogenesis of adult pneumonia in Papua New Guinea. Papua New Guinea Medical Journal
1991; 34: 13–16.
Dumouchelle, MW, Smith, KK, Qadri, SMH. Respiratory tract infections at a tertiary care centre: a seroepidemiological survey. Medical Science Research
1992; 20: 797–798.
Michetti, G, et al.
Community-acquired pneumonia: is there difference in etiology between hospitalized and out-patients?
1995; 86: 341–351.
Marrie, TJ, et al.
Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. American Journal of Medicine
1996; 101: 508–515.
Pareja, A, et al.
Etiologic study of patients with community-acquired pneumonia. Chest
1992; 101: 1207–1210.
Sillis, M, et al.
The differentiation of Chlamydia species by antigen detection in sputum specimens from patients with community-acquired acute respiratory infections. Journal of Infection
1992; 25: 77–86.
Mlinaric-Galinovic, G, et al.
Etiology of atypical pneumonia in children and adults. Paediatria Croatica
1995; 39: 247–251.
Gendrel, D, et al.
Etiology and response to antibiotic therapy of pneumonia in French children. European Journal of Clinical Microbiology & Infectious Diseases
1997; 16: 388–391.
Ishida, T, et al.
Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest
1998; 114: 1588–1593.
Rosón, B, et al.
Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clinical Infectious Diseases
2001; 33: 158–165.
Paganin, F, et al.
Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. European Respiratory Journal
2004; 24: 779–785.
Fernández-Sabé, N, et al.
Community-acquired pneumonia in very elderly patients: causative organisms, clinical characteristics, and outcomes. Medicine (Baltimore)
2013; 82: 159–169.
Garcia-Vidal, C, et al.
Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clinical Microbiology and Infection
2009; 15: 1033–1038.
Ruiz, M, et al.
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. American Journal of Respiratory and Critical Care Medicine
1999; 160: 397–405.
Socan, M, et al.
Microbial aetiology of community-acquired pneumonia in hospitalised patients. European Journal of Clinical Microbiology & Infectious Diseases
1999; 18: 777–782.
Tong, CYW, et al.
Multiplex polymerase chain reaction for the simultaneous detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Chlamydia psittci in respiratory samples. Journal of Clinical Pathology
1999; 52: 257–263.
Gutierrez, FJA, et al.
Prospective study of 221 community acquired pneumonias followed up in an outpatient clinic: etiology and clinical-radiological progression [in Spanish]. Medicina Clinica (Barcelona)
2001; 116: 161–166.
Luna, CM, et al.
Community-acquired pneumonia: etiology, epidemiology, and outcome at a teaching hospital in Argentina. Chest
2000; 118: 1344–1354.
Falguera, M, et al.
Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity. Archives of Internal Medicine
2001; 161: 1866–1872.
Saito, A, et al.
Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan. Journal of Infection and Chemotherapy
2006; 12: 63–69.
Beović, B, et al.
Aetiology and clinical presentation of mild community-acquired bacterial pneumonia. European Journal of Clinical Microbiology & Infectious Diseases
2003; 22: 584–591.
Gutiérrez, F, et al.
Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome. European Journal of Clinical Microbiology & Infectious Diseases
2005; 24: 377–383.
Strålin, K, et al.
Definite, probable, and possible bacterial aetiologies of community-acquired pneumonia at different CRB-65 scores. Scandavian Journal of Infectious Diseases
2010; 42: 426–434.
Kuzman, I, et al.
Clinical efficacy and safety of a short regimen of azithromycin sequential therapy vs standard cefuroxime sequential therapy in the treatment of community-acquired pneumonia: an international, randomized, open-label study. Journal of Chemotherapy
2005; 17: 636–642.
Briones, ML, et al.
Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults. Clinical and Vaccine Immunology
2006; 13: 1092–1097.
Sohn, JW, et al.
Atypical pathogens as etiologic agents in hospitalized patients with community-acquired pneumonia in Korea: a prospective multi-center study. Journal of Korean Medical Science
2006; 21: 602–607.
Ishida, T, et al.
A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology. Journal of Infection and Chemotherapy
2004; 10: 359–363.
Ewig, S, et al.
Factors associated with unknown aetiology in patients with community-acquired pneumonia. European Respiratory Journal
2002; 20: 1254–1262.
Ishiguro, T, et al.
Etiology and factors contributing to the severity and mortality of community-acquired pneumonia. Internal Medicine
2012; 52: 317–324.
Díaz, A, et al.
Etiology of community-acquired pneumonia in hospitalized patients in Chile: the increasing prevalence of respiratory viruses among classic pathogens. Chest
2007; 131: 779–787.
Charles, PGP, et al.
The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clinical Infectious Diseases
2008; 46: 1513–1521.
Walden, AP, et al.
Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort. Critical Care
2014; 18: 1–9.
Miyashita, N, et al.
Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between a teaching university hospital and a community hospital. Internal Medicine
2012; 51: 585–594.
Bütün, Y, et al.
Chlamydia and Mycoplasma serology in respiratory tract infections of children. Tüberküloz ve Toraks Dergisi
2006; 54: 254–258.
Capelastegui, A, et al.
Etiology of community-acquired pneumonia in a population-based study: link between etiology and patients characteristics, process-of-care, clinical evolution and outcomes. BMC Infectious Diseases
2012; 12: 134.
Spoorenberg, SMC, et al.
Chlamydia psittaci: a relevant cause of community-acquired pneumonia in two Dutch Hospitals. Netherlands Journal of Medicine
2016; 74: 75–81.
van Gageldonk-Lafeber, AB, et al.
The aetiology of community-acquired pneumonia and implications for patient management. Netherlands Journal of Medicine
2013; 71: 418–425.
Huijskens, EGW, et al.
Viral and bacterial aetiology of community-acquired pneumonia in adults. Influenza and Other Respiratory Viruses
2012; 7: 567–573.
Dumke, R, et al.
Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011–2012. Emerging Infectious Diseases
2015; 21: 426–433.
Raeven, VM, et al.
Atypical aetiology in patients hospitalised with community-acquired pneumonia is associated with age, gender and season; a data-analysis on four Dutch cohorts. BMC Infectious Diseases
2016; 16: 299.
Rozenbaum, MH, et al.
Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: a nationwide retrospective claims database analysis. Vaccine
2015; 33: 3193–3199.
Snijders, B, et al.
General practitioners’ contribution to the management of community-acquired pneumonia in the Netherlands: a retrospective analysis of primary care, hospital, and national mortality databases with individual data linkage. Primary Care Respiratory Journal
2013; 22: 400–405.
Cunha, BA. The atypical pneumonias: clinical diagnosis and importance. Clinical Microbiology and Infection
2006; 12(Suppl 3): 12–24.